Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Harvard Business School
Express Scripts
Boehringer Ingelheim
Moodys

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BARICITINIB

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Baricitinib

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01185353 A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy Completed Incyte Corporation Phase 2 2010-10-01 The purpose of this trial is to evaluate the safety and efficacy of LY3009104 in participants with Rheumatoid Arthritis (RA).
NCT01185353 A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy Completed Eli Lilly and Company Phase 2 2010-10-01 The purpose of this trial is to evaluate the safety and efficacy of LY3009104 in participants with Rheumatoid Arthritis (RA).
NCT01683409 A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease Completed Incyte Corporation Phase 2 2012-08-01 This is a dose ranging study to evaluate the safety and efficacy of baricitinib in the treatment of participants with mild to moderate diabetic kidney disease.
NCT01683409 A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease Completed Eli Lilly and Company Phase 2 2012-08-01 This is a dose ranging study to evaluate the safety and efficacy of baricitinib in the treatment of participants with mild to moderate diabetic kidney disease.
NCT01710358 A Study in Moderate to Severe Rheumatoid Arthritis Completed Eli Lilly and Company Phase 3 2012-10-01 The purpose of this study is to determine whether baricitinib is superior to placebo in the treatment of participants with moderately to severely active Rheumatoid Arthritis (RA) who have had an inadequate response to methotrexate (MTX) treatment.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Baricitinib

Condition Name

Condition Name for Baricitinib
Intervention Trials
Healthy Volunteers 10
Rheumatoid Arthritis 9
Atopic Dermatitis 9
Systemic Lupus Erythematosus 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Baricitinib
Intervention Trials
Arthritis 12
Arthritis, Rheumatoid 10
Dermatitis 10
Eczema 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Baricitinib

Trials by Country

Trials by Country for Baricitinib
Location Trials
United States 330
Japan 48
United Kingdom 46
Germany 39
Spain 28
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Baricitinib
Location Trials
Florida 18
California 17
Texas 17
Ohio 15
New York 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Baricitinib

Clinical Trial Phase

Clinical Trial Phase for Baricitinib
Clinical Trial Phase Trials
Phase 4 1
Phase 3 21
Phase 2/Phase 3 1
[disabled in preview] 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Baricitinib
Clinical Trial Phase Trials
Completed 17
Not yet recruiting 14
Recruiting 12
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Baricitinib

Sponsor Name

Sponsor Name for Baricitinib
Sponsor Trials
Eli Lilly and Company 43
Incyte Corporation 16
Wright State Physicians 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Baricitinib
Sponsor Trials
Industry 60
Other 6
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Harvard Business School
AstraZeneca
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.